Applied Materials Impairment and restructuring remained flat by 0.0% to $45.25M in Q3 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels indicate significant operational disruption or strategic realignment, often impacting short-term profitability.
The aggregate expense recognized for asset write-downs and costs associated with restructuring operations, such as facil...
Frequently used by capital-intensive firms to isolate non-recurring costs from core operating performance.
msft_impairment_and_restructuring| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $0.00 | $0.00 | $181.00M |